Does METFORMIN\PIOGLITAZONE Cause Bladder transitional cell carcinoma? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Bladder transitional cell carcinoma have been filed in association with METFORMIN\PIOGLITAZONE. This represents 3.4% of all adverse event reports for METFORMIN\PIOGLITAZONE.
17
Reports of Bladder transitional cell carcinoma with METFORMIN\PIOGLITAZONE
3.4%
of all METFORMIN\PIOGLITAZONE reports
2
Deaths
2
Hospitalizations
How Dangerous Is Bladder transitional cell carcinoma From METFORMIN\PIOGLITAZONE?
Of the 17 reports, 2 (11.8%) resulted in death, 2 (11.8%) required hospitalization.
Is Bladder transitional cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METFORMIN\PIOGLITAZONE. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does METFORMIN\PIOGLITAZONE Cause?
Bladder cancer (278)
Death (45)
Hypoglycaemia (27)
Lactic acidosis (15)
Sopor (13)
Bladder cancer recurrent (11)
Drug abuse (11)
Pneumonia (11)
Atrial fibrillation (10)
Peripheral swelling (10)
What Other Drugs Cause Bladder transitional cell carcinoma?
PIOGLITAZONE (398)
ADALIMUMAB (96)
METHOTREXATE (95)
RITUXIMAB (74)
TOCILIZUMAB (68)
INFLIXIMAB (63)
SULFASALAZINE (55)
HYDROXYCHLOROQUINE (50)
PREDNISONE (48)
LENALIDOMIDE (42)
Which METFORMIN\PIOGLITAZONE Alternatives Have Lower Bladder transitional cell carcinoma Risk?
METFORMIN\PIOGLITAZONE vs METFORMIN\ROSIGLITAZONE
METFORMIN\PIOGLITAZONE vs METFORMIN\SAXAGLIPTIN
METFORMIN\PIOGLITAZONE vs METFORMIN\SITAGLIPTIN
METFORMIN\PIOGLITAZONE vs METFORMIN\VILDAGLIPTIN
METFORMIN\PIOGLITAZONE vs METHADONE